Fig. 2. Initial treatment for (A) patients who are confirmed to be endometrial cancer after hysterectomy, and (B) patients diagnosed with an intermediate to high risk of recurrence after surgery performed with a presumed low risk of recurrence.

^*In the 2017 NCCN guidelines, observation is possible for patients with a tumor of <2 cm, LVSI negative, and a presumed low recurrence risk.